trending Market Intelligence /marketintelligence/en/news-insights/trending/g5s8wvxne4eczq8o6i5baa2 content esgSubNav
In This List

Evitrade to buy medical technology service company

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

Blog

Essential IR Insights Newsletter - February 2023


Evitrade to buy medical technology service company

Evitrade Health Systems Corp. is acquiring Cantech Molecular Research Inc.

Cantech Molecular Research manufactures plants grown through selective breeding and produces pharmaceutical products for agricultural and medicinal use.

Haywood Securities is acting as financial adviser to Evitrade.

Richmond, British Columbia-based Evitrade is a health technology company that provides biomedical online services for common health issues.